Endoscopy 2012; 44(S 02): E327-E328
DOI: 10.1055/s-0032-1309855
Unusual cases and technical notes
© Georg Thieme Verlag KG Stuttgart · New York

Endoscopic ultrasound-guided gold fiducial marker placement for intraoperative identification of insulinoma

J. Ramesh
1   Department of Gastroenterology and Hepatology, University of Alabama, Birmingham, Alabama, USA
,
J. Porterfield
2   Department of Surgery, University of Alabama, Birmingham, Alabama, USA
,
S. Varadarajulu
1   Department of Gastroenterology and Hepatology, University of Alabama, Birmingham, Alabama, USA
› Author Affiliations
Further Information

Corresponding author

J. Ramesh, MD
Division of Gastroenterology and Hepatology
University of Alabama at Birmingham
BDB 389
1808 7th Avenue South
Birmingham
AL 35294
USA   
Fax: +1-205-975-6381   

Publication History

Publication Date:
25 September 2012 (online)

 

Insulinomas are the most common functioning pancreatic neuroendocrine neoplasm, comprising 30 % – 45 % of these tumors. Although laparoscopic resection is safe, minimally invasive, and is associated with shorter length of hospital stay, tumor localization at surgery can be challenging. We describe endoscopic ultrasound (EUS)-guided fiducial placement as a new technique for intraoperative localization of pancreatic insulinoma.

A 36-year-old woman with episodes of confusion that resolved with intake of glucose and whose laboratory tests were suggestive of insulinoma was referred for laparoscopic distal pancreatectomy. Linear-array EUS (GF-UCT 240; Olympus Corp., Center Valley, Pennsylvania, USA) confirmed a tail mass ([Fig. 1]). After retracting the stylet of the fine-needle aspiration (FNA) needle (Expect 19-gauge Flex needle; Boston Scientific Corp., Natick, Massachusetts, USA) by 2 cm, one gold fiducial (3 × 0.8 mm; Best Medical International, Springfield, Virginia, USA) was back-loaded into the lumen of the needle and sealed with bone wax. At EUS, the fiducials were deployed within the tumor by advancing the stylet forward ([Fig. 2]). Overall, two fiducials were deployed ([Fig. 3]), and a preoperative computed tomography (CT) scan confirmed their position. At laparoscopy, the fiducials were identified using cross-table fluoroscopy ([Fig. 4]), and distal pancreatectomy with splenectomy was performed. A frozen section confirmed negative tumor margins, and the explant specimen revealed the tumor with fiducials in place ([Fig. 5]). Final pathological analysis revealed T1 N0 grade II pancreatic neuroendocrine neoplasm ([Fig. 6]).

Zoom
Fig. 1 Linear-array endoscopic ultrasound (EUS) image of the isoechoic mass lesion in the tail of pancreas, superior to the left kidney.
Zoom
Fig. 2 Fluoroscopic image showing the linear-array echoendoscope with the 19-gauge fine-needle aspiration (FNA) needle and the first fiducial.
Zoom
Fig. 3 Endoscopic ultrasound (EUS) image showing the markers within the lesion casting an acoustic shadow (arrow).
Zoom
Fig. 4 Intraoperative fluoroscopic image with the stapler gun in place. The two fiducial markers can be easily visualized.
Zoom
Fig. 5 Postoperative specimen of the pancreas, showing the fiducial marker within the lesion.
Zoom
Fig. 6 Postoperative histological specimen showing uniform sheets of polyhedral cells with hyperchromatic nuclei and abundant eosinophilic cytoplasm, consistent with a neuroendocrine neoplasm (hematoxylin and eosin stain, × 40).

Preoperative injection of India ink [1] or indocyanine green [2] under EUS guidance was developed to facilitate quick tumor localization and to decrease operative time and blood transfusion requirements [3]. However, the disadvantages of dyes include peritonitis, infection, allergic reactions, and reabsorption within tissue planes [4]. In this report, we have described the use of fiducials as an alternative technique for this indication. The fiducials are inexpensive ($ 80 for five fiducials), easy to deploy, can be identified readily using fluoroscopy or intraoperative ultrasound, and (unlike dyes) do not extravasate into surrounding tissue.

Endoscopy_UCTN_Code_TTT_1AS_2AD


Competing interests: Dr Varadarajulu is a Consultant for Boston Scientific Corporation and Olympus Corporation.


Corresponding author

J. Ramesh, MD
Division of Gastroenterology and Hepatology
University of Alabama at Birmingham
BDB 389
1808 7th Avenue South
Birmingham
AL 35294
USA   
Fax: +1-205-975-6381   


Zoom
Fig. 1 Linear-array endoscopic ultrasound (EUS) image of the isoechoic mass lesion in the tail of pancreas, superior to the left kidney.
Zoom
Fig. 2 Fluoroscopic image showing the linear-array echoendoscope with the 19-gauge fine-needle aspiration (FNA) needle and the first fiducial.
Zoom
Fig. 3 Endoscopic ultrasound (EUS) image showing the markers within the lesion casting an acoustic shadow (arrow).
Zoom
Fig. 4 Intraoperative fluoroscopic image with the stapler gun in place. The two fiducial markers can be easily visualized.
Zoom
Fig. 5 Postoperative specimen of the pancreas, showing the fiducial marker within the lesion.
Zoom
Fig. 6 Postoperative histological specimen showing uniform sheets of polyhedral cells with hyperchromatic nuclei and abundant eosinophilic cytoplasm, consistent with a neuroendocrine neoplasm (hematoxylin and eosin stain, × 40).